BioNTech SE (BNTX) Reports Q2 EPS of EUR6.45

BioNTech SE (NASDAQ: BNTX) reported Q2 EPS of EUR6.45. Revenue for the quarter came in at EUR3.2 billion.

The company reiterated BioNTech COVID-19 2022 vaccine revenue guidance of €13 billion to €17 billion.

For earnings history and earnings-related data on BioNTech SE (BNTX) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• Bernstein SocGen Group Upgrades Engie SA (ENGI:FP) (ENGIY) to Outperform
• Cematrix wins $8.8M in new contracts, bringing YTD total to $43.2M